Hepatitis B virus resistance to antivirals: clinical implications and management

被引：18

作者：

Zoulim, F

机构：

[1] Inst Univ France, INSERM, U271, F-69003 Lyon, France

[2] Inst Univ France, Liver Dept, F-69003 Lyon, France

来源：

JOURNAL OF HEPATOLOGY | 2003年 / 39卷

关键词：

D O I：

10.1016/S0168-8278(03)00312-X

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S133 / S138

页数：6

共 45 条

[1] Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B [J].

Ahmed, SNS ;

Tavan, D ;

Pichoud, C ;

Berby, F ;

Stuyver, L ;

Johnson, M ;

Merle, P ;

Abidi, H ;

Trépo, C ;

Zoulim, F .

HEPATOLOGY, 2000, 32 (05) :1078-1088

[2] Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study [J].

Benhamou, Y ;

Bochet, M ;

Thibault, V ;

Calvez, V ;

Fievet, MH ;

Vig, P ;

Gibbs, CS ;

Brosgart, C ;

Fry, J ;

Namini, H ;

Katiama, C ;

Poynard, T .

LANCET, 2001, 358 (9283) :718-723

[3] HEPATITIS-B VIRUS UNABLE TO SECRETE E-ANTIGEN AND RESPONSE TO INTERFERON IN CHRONIC HEPATITIS-B [J].

BRUNETTO, MR ;

GIARIN, M ;

SARACCO, G ;

OLIVERI, F ;

CALVO, P ;

CAPRA, G ;

RANDONE, A ;

ABATE, ML ;

MANZINI, P ;

CAPALBO, M ;

PIANTINO, P ;

VERME, G ;

BONINO, F .

GASTROENTEROLOGY, 1993, 105 (03) :845-850

[4] Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection [J].

Colonno, RJ ;

Genovesi, EV ;

Medina, I ;

Lamb, L ;

Durham, SK ;

Huang, ML ;

Corey, L ;

Littlejohn, M ;

Locarnini, S ;

Tennant, BC ;

Rose, B ;

Clark, JM .

JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (10) :1236-1245

[5] The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss [J].

de Man, RA ;

Bartholomeusz, AI ;

Niesters, HGM ;

Zondervan, PE ;

Locarnini, SA .

JOURNAL OF HEPATOLOGY, 1998, 29 (04) :669-675

[6] Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus [J].

Delaney, WE ;

Edwards, R ;

Colledge, D ;

Shaw, T ;

Torresi, J ;

Miller, TG ;

Isom, HC ;

Bock, CT ;

Manns, MP ;

Trautwein, C ;

Locarnini, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1705-1713

[7] Lamivudine as initial treatment for chronic hepatitis B in the United States [J].

Dienstag, JL ;

Schiff, ER ;

Wright, TL ;

Perrillo, RP ;

Hann, HWL ;

Goodman, Z ;

Crowther, L ;

Condreay, LD ;

Woessner, M ;

Rubin, M ;

Brown, NA .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) :1256-1263

[8]

Ghany MG, 2000, HEPATOLOGY, V32, p376A, DOI 10.1053/jhep.2000.17912

[9] Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection [J].

Gish, RG ;

Leung, NWY ;

Wright, TL ;

Trinh, H ;

Lang, W ;

Kessler, HA ;

Fang, L ;

Wang, LH ;

Delehanty, J ;

Rigney, A ;

Mondou, E ;

Snow, A ;

Rousseau, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) :1734-1740

[10] Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B [J].

Hadziyannis, SJ ;

Papatheodoridis, GV ;

Dimou, E ;

Laras, A ;

Papaioannou, C .

HEPATOLOGY, 2000, 32 (04) :847-851

← 1 2 3 4 5 →